缩写名/全名 |
PHARMACOECONOMICS
PHARMACOECONOMICS |
||||||||||||||||||||||||
ISSN号 | 1170-7690 | ||||||||||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||||||||||
影响因子 | 2015:2.566, 2016:3.63, 2017:3.989, 2018:3.705, 2019:3.563, | ||||||||||||||||||||||||
出版国家 | NEW ZEALAND | ||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||
年文章数 | 109 | ||||||||||||||||||||||||
出版年份 | 1992 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | https://www.editorialmanager.com/peca/ | ||||||||||||||||||||||||
投稿官网 | http://link.springer.com/journal/40273 | ||||||||||||||||||||||||
h-index | 91 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1170-7690%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
中国学者近期发表的论文 | |
1. | Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial Author: Fuxiao Li, Xiang Li, Chuanhai Guo, Ruiping Xu, Fenglei Li, Yaqi Pan, Mengfei Liu, Zhen Liu, Chao Shi, Hui Wang, Minmin Wang, Hongrui Tian, Fangfang Liu, Ying Liu, Jingjing Li, Hong Cai, Li Yang, Zhonghu He, Yang Ke Journal: PHARMACOECONOMICS, 2019, Vol., , DOI:10.1007/s40273-019-00766-9 DOI |
2. | Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009) Author: Lizheng Shi, Heidi Y. Yang, Gang Cheng, Qingyue Meng Journal: PHARMACOECONOMICS, 2013, Vol.32, 257-264, DOI:10.1007/s40273-013-0072-3 DOI |
3. | Impacts of Health Insurance Benefit Design on Percutaneous Coronary Intervention Use and Inpatient Costs among Patients with Acute Myocardial Infarction in Shanghai, China Author: Suwei Yuan, Yan Liu, Na Li, Yunting Zhang, Zhe Zhang, Jingjing Tao, Lizheng Shi, Hude Quan, Mingshan Lu, Jin Ma Journal: PHARMACOECONOMICS, 2013, Vol.32, 265-275, DOI:10.1007/s40273-013-0079-9 DOI |
4. | Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals Author: Jing Wu, Judy Xu, Gordon Liu, Jiuhong Wu Journal: PHARMACOECONOMICS, 2013, Vol.32, 293-303, DOI:10.1007/s40273-013-0099-5 DOI |
5. | Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer Author: Tan Chongqing, Peng Liubao, Zeng Xiaohui, Li Jianhe, Wan Xiaomin, Chen Gannong, Wang Siying, Ouyang Lihui, Zhao Ziying Journal: PHARMACOECONOMICS, 2013, Vol.32, 235-243, DOI:10.1007/s40273-013-0065-2 DOI |
6. | Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes Author: Jinsong Geng, Hao Yu, Yiwei Mao, Peng Zhang, Yingyao Chen Journal: PHARMACOECONOMICS, 2015, Vol.33, 581-597, DOI:10.1007/s40273-015-0266-y DOI |
7. | Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension Author: Shuyan Gu, Huimei Hu, Hengjin Dong Journal: PHARMACOECONOMICS, 2016, Vol.34, 751-770, DOI:10.1007/s40273-016-0395-y DOI |
8. | Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension Author: Shuyan Gu, Huimei Hu, Hengjin Dong Journal: PHARMACOECONOMICS, 2015, Vol.34, 533-550, DOI:10.1007/s40273-015-0361-0 DOI |
9. | Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China Author: Yuqing Tang, Chaojie Liu, Junjie Liu, Xinping Zhang, Keyuan Zuo Journal: PHARMACOECONOMICS, 2018, Vol.36, 995-1004, DOI:10.1007/s40273-018-0654-1 DOI |
10. | Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension. Author: Gu S, Hu H, Dong H. Journal: Pharmacoeconomics. 2016 Jun;34(6):533-50. doi: 10.1007/s40273-015-0361-0. Review. PubMed |
|
|